MERLIN DIAMONDS LIMITED (ASX.MED)

a loss declaration has been issued and the capital loss can therefore be claimed in the financial year the declaration is issued (this declaration was issued on 29 June 2022)

Liquidators confirm that the sale of the Merlin mine has been completed and aim to provide an update to all stakeholders regarding the Liquidation early next year. They are anticipating that a distribution will be available to some of the creditors, however it is unlikely at this stage that shareholders will receive a distribution. A distribution will only be declared once their investigations are completed, any further investigations conducted may delay the timeframe on completing a distribution.

liquidators are in the middle of a sales process and will know only in a couple of months as to whether they will be in a position to make a declaration of loss

Salvatore Algeri and Tim Norman of Deloitte are appointed Joint and Several Liquidators of the Company

we understand this company failed and is in liquidation and ASX removed the company from listing because its securities have not been quoted for "an unacceptably long period"

delisted from the commencement of trading on 16 March 2020 pursuant to Listing rule 17.12.

Justice OBryan appointed Mr Salvatore Algeri and Mr Timothy Norman, of Deloitte Financial Advisory Pty Ltd, as joint and several provisional liquidators to Merlin.

The company lodges its Fourth Quarter Cashflow Report.

ASIC is applying to the court for the appointment of Mr Salvatore Algeri and Mr Timothy Norman, of Deloitte Financial Advisory Pty Ltd as joint and several provisional liquidators of the company because of concerns including: since 2012, Merlin Diamonds has advanced substantial funds to Axis Consultants Pty Ltd (Axis), a related management services company, without shareholder approval ($13,752,124 owing as at 30 June 2018) (Loans); the Loans have been used to fund private companies associated with Mr Joseph Gutnick (a current and former director of Merlin Diamonds and Axis respectively) and provide no discernible benefit to Merlin Diamonds; the terms of the Loans appear to be unreasonable, uncommercial and non-arm's length. No security for the Loans has been provided by Axis or any third party and the Loans are being fully provisioned (impairment provision) each financial year; the Merlin Diamonds auditors have been unable to obtain sufficient appropriate audit evidence to be satisfied that Axis is likely to be able to repay the Loans.

The company lodges its Third Quarter Activities Report & Cashflow Reports.

Following the receipt by MED of ASX's letter and prior to the deadline for its response, MED sought a meeting with ASX to discuss the actions MED needed to take to allow MED's shares to be reinstated to trading on ASX. On that basis, ASX granted MED a two week extension to respond to ASX's query letter to put a proposal to ASX that, if acceptable to ASX, might see MED's shares reinstated to trading on ASX. Although MED outlined such a proposal in its market release dated 11 February 2019 headed "˜Update on Suspension', ASX has not received any details of the proposal from MED for it to consider, nor has it received a response to its query letter to MED dated 4 January 2019.

Merlin and ASX met recently and as a rersult: Merlin is prepared to reconstitute the board so that it comprises a majority of independent directors; also to terminate the service deed dated 31 August 2009 between MED and Axis Consultants; the independent directors to determine the appropriate arrangements to address the debt between MED and AXIS. MED agrees that if necessary a meeting of the shareholders would be calle to ratify such an arrangement.

The company lodges its Second Quarter Activities and Cashflow Report.

The company releases the results of its meeting.

Merlin Diamonds and ASX met on Monday 5 November 2018. Following that meeting, MED has determined that two independent non-executive directors would be appointed to the Board of Directors of MED and the Board will then review and revisit the queries and answers to the ASX from the 9,17, and 29 October 2018. If ASX is satisfied with the outcome of the Board Review, MED expects its securities to be reinstated to quotation on ASX soon thereafter.

Trading in MED's securities will remain suspended until the matters raised by ASX in its query letters dated 9, 17 and 29 October 2018 have been addressed to its satisfaction.

The company issues responses to ASX Queries.

The company lodges its Quarterly Activities Report.

The company releases a notice of meeting. The Annual General Meeting of Merlin Diamonds Limited will be held at Pullman Albert Park, 65 Queens Road, Melbourne, Victoria 3004, Australia, on 30 November 2018, commencing at 9.00 am.

The securities of Merlin Diamonds Limited were suspended from quotation on 1 October 2018 following its failure to lodge audited accounts for the year ended 30 June 2018 by the due date in listing rule 4.5. MED lodged its accounts on 8 October 2018, following which ASX raised certain queries in relation to the auditor's report. MED's responses to the queries were released to the market today. MED's securities will remain suspended in accordance with listing rule 17.3, pending further queries from ASX.

The company issues responses to ASX Queries.

The company lodges its Full Year Statutory Accounts.

The Company advises that 4,000,000 incentive options have expired.

The company releases an Appendix 4G.

The company releases a report on governance.

The securities of the company will be suspended from Official Quotation in accordance with Listing Rule 17.5 from the commencement of trading today, 1 October 2018, following failure to lodge the relevant periodic report for the period ended 30 June 2018 by the due date.

The securities of Merlin Diamonds Limited (the "Company") will be reinstated to quotation immediately, following the release of an announcement by the Company. Security Code: MED

a General Meeting of Merlin Diamonds Limited (the "Company") will be held at Pullman Albert Park, 65 Queens Road Melbourne Vic 3004 Australia, on 29 April 2015, commencing at 10.15 am

due to a change of strategy in the capital raising, the Directors request ASX to continue the suspension of trading in Merlin Diamonds Limited. Roadshows have been organised over the next week. Given the religious holidays in the Jewish and Christian calendar, the Company expects to be able to make an announcement after the holidays

The securities of Merlin Diamonds Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement by the Company in relation to a proposed capital raising. Security Code: MED

name changed from North Australian Diamonds Ltd